Every grant database has the same assumption baked into it: an eligible applicant is an organization. You are a nonprofit, a university, a county, a company. The database matches your attributes against a program’s rules and tells you whether you can apply.
There is a family of federal listings where that model breaks, and it breaks in a way that is easy to miss because the listings look ordinary. They carry a funder, a posted deadline, a Grants.gov detail page, and a route to submit. Five are indexed on OpenGrants right now, all from the National Institutes of Health. On every one, eligibility turns not on an attribute of your organization but on whether you already hold a specific NIH award.
That is not a technicality about who gets priority. It is the gate. Without a parent award, there is nothing for these announcements to act on, because none of them starts a project. They move one, expand one, or hand one to somebody else.
Read together, the five make visible what no single listing shows: inside one apparent category — “NIH funding opportunity” — sit three different processes, two review paths, and a timing rule living in a document the listing never links.
The Applicant Is an Award
Start with what the records say plainly.
The Administrative Supplements to Existing NIH Grants and Cooperative Agreements parent announcement opens with the condition rather than burying it: current recipients of specific types of NIH research grants may apply for administrative supplements to provide additional funding to a currently funded grant. The money is for costs that are, in the record’s phrasing, within the scope of the peer-reviewed and approved project but were unforeseen when the new or competing renewal application was awarded.
Two conditions are stacked there, both restrictive. You need a currently funded grant, and the increased cost has to sit inside a scope somebody already reviewed and approved. A supplement is not an opportunity to do a new thing with NIH money; it is a request to finish the approved thing at a price nobody anticipated.
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements is addressed, in the record’s own words, to NIH award recipients — notifying them that funds may be available for revision applications to support the expansion of existing projects and/or programs. Again the object is an existing project.
Emergency Competitive Revision to Existing NIH Awards puts the dependency in its title. The record describes funds that may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary of HHS, or other local, regional or national disaster.
And then the two that go furthest.
Two Listings, Five Days Apart, One Word of Difference
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) and Successor-in-Interest (Type 6 Parent Clinical Trial Optional) are, at a glance, the same listing published twice. Same funder. No award amount indexed on either. Deadlines five days apart — July 12, 2027 for Type 7, July 17, 2027 for Type 6. Descriptions that track each other almost sentence for sentence: both notify recipient organizations holding specific types of NIH grants that applications may be submitted, both call the submission a prior approval request, both route it to the Grants Management Specialist named in the current award, and both say — in the same words — that there is no guarantee that an award will be transferred to the new organization.
The difference is a single reference. Type 7 cites Section 8.1.2.7 of the NIH Grants Policy Statement. Type 6 cites Section 8.1.2.8, and its description gives the request a different name: change of recipient organization status, often referred to in that announcement as Successor-In-Interest.
That one word, status, is the distinction: an award moving, versus an organization changing shape underneath an award that never moves. A successor-in-interest is what you file when the legal entity holding the grant becomes a different legal entity — the sort of thing a merger, an acquisition, or a change of incorporation produces. Nothing relocates; the name on the award has to catch up with reality. A change of recipient organization is the other case: the work goes somewhere else.
Both records point at the same consequence, unusual enough to state directly. In each, the organization submitting the application is not the organization that holds the grant. The applicant has never been the recipient. What is requested is not money but custody of money that already exists — and the record is explicit that requesting it does not get it.
Type 7’s record adds a condition the other does not: the announcement, it says, assumes such a change is programmatically permitted for the particular grant. Some awards can move. The record does not say which, beyond pointing at an Activity Code section in the full announcement that the indexed summary does not reproduce — so that is the first thing to establish, and it is not answerable from the listing.
Nobody Is Promising You the Money
The most useful sentences in this group are the disclaimers, because they are unusually blunt for a funding announcement.
Both transfer records state there is no guarantee that an award will be transferred to the new organization. The administrative supplement record goes further: no guarantee that funds are available from the awarding Institute or Center, or for any specific grant. A posted, open, indexed federal funding announcement telling you up front that the money behind it may not exist for your case.
Which is why all three give the same instruction, in escalating language. The two transfer announcements say applicants are encouraged to discuss potential requests with the awarding Institute or Center before submission. The supplement record does not encourage: it says applicants must discuss potential requests with the awarding Institute’s grants and program officials prior to submission.
That inverts the normal sequence. In a competition, talking to the program officer is preparation and the application is the event. Here the conversation is closer to the event itself, and the submission records a decision that has largely already been shaped. Filing first is not aggressive; it is skipping the step where you find out whether there is anything to file for.
One Family, Two Completely Different Reviews
Group these five as “NIH post-award opportunities” and you will get the process wrong, because they do not share one.
Three of them route around scientific review entirely. Type 6 and Type 7 requests are routed for consideration directly to the Grants Management Specialist named in the current award. Administrative supplements are routed directly to the Grants Management Officer of the parent award. In all three, the submission lands on a named individual already attached to your grant. It is an administrative determination.
Competing Revisions is a different animal wearing the same coat. Its record states that revision applications will be evaluated for scientific and technical merit by an appropriate Scientific Review Group, in accordance with NIH peer review policy and procedures. That is the full apparatus — a real competition, judged on science, that happens to require you to already hold the award being revised.
The Emergency Competitive Revision record describes a third routing: applications in response to Emergency Notices of Special Interest are routed directly to the NIH awarding component signed on to the Emergency NOSI.
So the label tells you little about the work involved, and preparing for the wrong one is the expensive mistake here.
The Date in the Deadline Field Is Not the Gate
Both revision announcements carry a rule that makes their own posted deadlines close to irrelevant.
The Competing Revisions record states that only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this NOFO. The Emergency Competitive Revision record states the same thing about Emergency NOSIs: only applications submitted in response to an Emergency NOSI published by an Institute or Center will be allowed to apply.
The indexed deadlines are November 24, 2026 and April 18, 2027 respectively. Neither is a date you can plan an application around, because permission to apply at all comes from a separate document — a Notice of Special Interest — published on its own schedule by an individual Institute, naming its own scope and its own dates. Until one exists that covers your work, the announcement is not open to you in any operational sense. Once one does, its terms govern.
The failure mode is specific: the listing is genuinely open, the deadline is genuinely real, and the thing deciding whether you may apply is in a document the listing does not name. A calendar reminder set from the deadline field tracks the wrong object.
The five-day gap between the two transfer announcements points the same direction. Both records tell you to talk to the awarding Institute before submitting, and that instruction — not the date — is the timing guidance they actually offer.
One inconsistency is worth flagging rather than smoothing over. The Emergency Competitive Revision is titled as a revision to existing NIH awards, but its description addresses the applicant community generally rather than award recipients specifically, the way the other four do. Whether it reaches organizations without a parent award is not resolvable from the record — confirm against the official listing and the governing Emergency NOSI.
Why the Machinery Looks Like This
None of this is accidental, and the logic generalizes past NIH.
Federal awards come with rules about what the recipient may change without asking. Move the work to a new institution, redirect the scope, spend past the approved budget — each needs the agency’s permission first. That mechanism is prior approval, and three of these five records name themselves as exactly that.
NIH’s choice was to accept those requests through the same submission system that handles competitive applications — one intake, one identity system, one audit trail. The side effect is that a prior-approval request acquires the surface markings of a funding opportunity: an announcement number, a posted deadline, a Grants.gov page, and an entry in every database that indexes Grants.gov, including ours.
The listing is accurate and still misleading, in the way a form can be. It is a faithful description of a real thing that is not a competition, and nothing about the shape of the entry says so.
What This Changes If You Hold an NIH Award
Four practical consequences, none of which follow from a standard grant-seeking posture.
Your existing award is an eligibility asset, and it is invisible in most searches. Filtering a grant database by organization type will never surface these; the qualifying attribute is a grant number. If your institution holds NIH awards, somebody should be reading post-award announcements as part of the same routine that scans for new competitions.
The conversation precedes the application, and for supplements it is mandatory. The supplement record uses must. Build the timeline backwards from a program-official conversation, not forwards from a submission date.
Establish whether your specific award can do the thing before you plan on it. Type 7’s record says it assumes the change is programmatically permitted for the particular grant. Some awards travel and some do not, and the answer is a property of your award, not of the announcement.
Know which review you are entering. A competing revision faces a Scientific Review Group and needs to be written as science. A supplement or a transfer goes to a named administrator on your grant and needs to be written as a justified request — different documents, different people, different schedules.
Before You File
For Type 7, Change of Recipient Organization, confirm first that a transfer is programmatically permitted for your specific award — the record makes that an assumption, not a promise. Note who is applying: the receiving organization submits, and it has never held the grant. Talk to the awarding Institute before anything else, and treat the record’s plain statement that there is no guarantee of transfer as a real risk rather than boilerplate.
For Type 6, Successor-in-Interest, establish which case you are in. If the legal entity changed and the work stayed put, this is your announcement rather than Type 7. The two records are close enough to be confused and cite different sections of the NIH Grants Policy Statement — 8.1.2.8 here, 8.1.2.7 there.
For Administrative Supplements, test the request against two filters before drafting: is the cost within the scope of the peer-reviewed and approved project, and was it unforeseen at the time of award. A cost that fails either is not a supplement request.
For Competing Revisions, find the Notice of Special Interest first. Without one from the relevant Institute, the record says you are not permitted to apply, whatever the posted November 24, 2026 date suggests. Once you have one, plan for full scientific and technical merit review.
For the Emergency Competitive Revision, the trigger is external — a declared disaster or public health emergency and an Emergency NOSI published against it. Nothing here is plannable in advance except knowing it exists and knowing which of your awards could carry the work.
None of the five records indexes an award amount. Where a figure matters to your planning, this post does not supply one — see each listing, and confirm with the awarding Institute.
The Bottom Line
The federal grant system contains a whole class of announcements that are not offers. They are procedures with announcement numbers, indexed alongside real competitions because they arrive through the same door.
For an organization that already holds federal awards, that is useful once you see it: there is machinery for moving an award, expanding it, and topping it up, documented in public rather than hidden in a program officer’s inbox. For an organization that holds none, these five listings are noise — and the fastest way to tell the two apart is to read past the deadline field to the sentence naming who may apply.
That sentence is worth reading first on any listing, and it is the one most often skipped. OpenGrants indexes more than 43,000 open funding opportunities across federal, state, local, foundation, and corporate sources, searchable free with no account, with that eligibility language kept alongside the basics rather than summarized away. Search the OpenGrants grant database for programs your organization can actually enter, read how research funding works at NIH and NSF, learn how to read a NOFO, and use the OpenGrants knowledge base to set up alerts.
Start free at ops.opengrants.io.
Every deadline, eligibility rule, routing detail, and policy-section citation above comes from the five NIH program records indexed on OpenGrants and linked here. None states an award amount, and this post does not estimate one. Confirm current terms against each official listing and with the awarding Institute or Center before filing.